Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
World Journal of Urology|September 26, 2019
Psychometric validation of the German version of the EPIC-26 questionnaire for patients with localized and locally advanced prostate cancerNora Tabea Sibert, Sebastian Dieng, Alisa Oesterle, et al.
Oncoimmunology|October 23, 2023
<i>PD-L1</i> (<i>CD274</i>) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinomaNiklas Klümper, Lennert Wüst, Jonas Saal, et al.
The Journal of Urology|January 4, 2014
The health care burden of skeletal related events in patients with renal cell carcinoma and bone metastasisCarina Antczak, Vincent Q Trinh, Akshay Sood, et al.
Urologic Oncology|December 3, 2014
The burden of skeletal-related events in patients with prostate cancer and bone metastasisFlorian Roghmann, Carina Antczak, Rana R McKay, et al.
BJU International|May 8, 2024
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC MonitorMaximilian Haas, Maximilian C Kriegmair, Johannes Breyer, et al.
Scientific Reports|September 18, 2023
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)Johannes Breyer, Markus Eckstein, Danijel Sikic, et al.
European Urology|October 22, 2013
Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over timeGuillaume Ploussard, Shahrokh F Shariat, Alice Dragomir, et al.
Urologic Oncology|March 3, 2018
Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer networkTahlita C M Zuiverloon, Kim E M van Kessel, Trinity J Bivalacqua, et al.
Pageof 15